MedTrace Logo

Indolent Non Follicular Lymphomas Prognostic Project

NCT02904577 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 370

Last updated 2025-08-08

No results posted yet for this study

Summary

Prospective collection of data of possible prognostic relevance in patients with indolent non - follicular B-CELL Lymphomas.

Conditions

  • Indolent B-Cell Lymphomas

Interventions

OTHER

Any treatment, watch and wait policy included

Patients registered in the study despite their planned treatment, watch and wait policy included. The "planned treatment" mentioned in the protocol is just the ideal approach proposed by investigators.The treatment can change depending on the evolution of the disease, without this affects the study's purposes.

Sponsors & Collaborators

  • Fondazione Italiana Linfomi - ETS

    lead OTHER

Principal Investigators

  • Arcaini Luca, MD · Divisione di Ematologia IRCCS Policlinico S. Matteo Pavia

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-09-30
Primary Completion
2024-12-31
Completion
2024-12-31

Countries

  • Austria
  • Brazil
  • France
  • Italy
  • Portugal
  • Ukraine

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02904577 on ClinicalTrials.gov